Literature DB >> 28069286

Hepatic Encephalopathy.

Adam G Gow1.   

Abstract

This article reviews hepatic encephalopathy (HE) in companion animals. Clinical signs and categories of hepatic disease likely to cause HE are discussed. Ammonia has a key role in pathogenesis and current concepts in body ammonia metabolism are reviewed. Inflammation and manganese accumulation are also thought to be important in pathogenesis. Treatment of HE in acute and chronic cases is discussed along with the rationale for current treatment recommendations. Potential avenues for new treatments and human treatments, which may be transferable to companion animals, are reviewed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ammonia; Inflammation; Manganese; Neurotransmitter; Portosystemic shunting

Mesh:

Substances:

Year:  2017        PMID: 28069286     DOI: 10.1016/j.cvsm.2016.11.008

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  9 in total

1.  The Role of Gut Microbiota in Mice With Bile Duct Ligation-Evoked Cholestatic Liver Disease-Related Cognitive Dysfunction.

Authors:  Bowen Yang; Tianning Sun; Yingle Chen; Hongbing Xiang; Jun Xiong; Shiting Bao
Journal:  Front Microbiol       Date:  2022-05-10       Impact factor: 6.064

2.  Hepatoprotective and neuroprotective effect of taxifolin on hepatic encephalopathy in rats.

Authors:  Ufuk Okkay; Irmak Ferah Okkay; Betul Cicek; Ismail Cagri Aydin; Mustafa Ozkaraca
Journal:  Metab Brain Dis       Date:  2022-03-17       Impact factor: 3.655

3.  The effect of ammonia on canine polymorphonuclear cells.

Authors:  Craig R Breheny; Richard J Mellanby; Julie A Hamilton; Adam G Gow
Journal:  Vet Res Commun       Date:  2018-06-24       Impact factor: 2.459

4.  The effects of thymoquinone on memory impairment and inflammation in rats with hepatic encephalopathy induced by thioacetamide.

Authors:  Somayeh Hajipour; Alireza Sarkaki; Mahin Dianat; Mohammad Rashno; Laaya Sadat Khorsandi; Yaghoob Farbood
Journal:  Metab Brain Dis       Date:  2021-02-23       Impact factor: 3.584

5.  Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs.

Authors:  Tarini Ullal; Yoko Ambrosini; Sangeeta Rao; Cynthia R L Webster; David Twedt
Journal:  J Vet Intern Med       Date:  2019-08-08       Impact factor: 3.333

6.  Hepatoprotective effect of sodium hydrosulfide on hepatic encephalopathy in rats.

Authors:  Kyoung Wan Kwon; Yoonjin Nam; Won Seok Choi; Tae Wook Kim; Geon Min Kim; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2019-06-25       Impact factor: 2.016

7.  ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.

Authors:  Cynthia R L Webster; Sharon A Center; John M Cullen; Dominique G Penninck; Keith P Richter; David C Twedt; Penny J Watson
Journal:  J Vet Intern Med       Date:  2019-03-07       Impact factor: 3.333

8.  Characterization of the Fecal Microbiome in Dogs Receiving Medical Management for Congenital Portosystemic Shunts.

Authors:  Nathan Squire; Cassie Lux; Katie Tolbert; Jonathan Lidbury; Xiaocun Sun; Jan S Suchodolski
Journal:  Front Vet Sci       Date:  2022-07-28

9.  Outcome of non-surgical dietary treatment with or without lactulose in dogs with congenital portosystemic shunts.

Authors:  Robert P Favier; Eline de Graaf; Ronald J Corbee; Anne Kummeling
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.